Proposal for harmonizing the reporting of infections during treatment with bispecific antibodies in multiple myeloma
Blood Adv
.
2024 May 22:bloodadvances.2024013461.
doi: 10.1182/bloodadvances.2024013461.
Online ahead of print.
Authors
Heinz Ludwig
1
,
Nikhil C Munshi
2
,
Evangelos Terpos
3
,
Ilvy Schweitzer
1
,
Noopur Raje
4
,
Philippe Moreau
5
,
Ajay K Nooka
6
Affiliations
1
Wilhelminen Cancer Research Institute, Vienna, Austria.
2
Dana Farber Cancer Institute, Boston, Massachusetts, United States.
3
National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
4
Massachusetts General Hospital, Boston, Massachusetts, United States.
5
Hematology, University Hospital Hôtel-Dieu, Nantes, France.
6
Emory University Winship Cancer Institute, Atlanta, Georgia, United States.
PMID:
38776433
DOI:
10.1182/bloodadvances.2024013461
No abstract available